 Clinical-stage biotechnology firm Tonix Pharmaceuticals NASDAQ: TNXP which focuses on novel therapeutics and diagnostics is making waves today, announcing the issuance of a patent. Specifically, the U.S. Patent and Trademark Office or USPTO granted a patent on TNX-1900 for the indication of treating pain, including that stemming from migraine headaches. 